close
Enquiry IconContact Us
Logo

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Active pharmaceutical ingredient (API) is any substance or combination of substances used in a finished pharmaceutical product (FPP) to provide pharmacological activity or to otherwise have a direct effect in disease diagnosis, cure, mitigation, treatment, or prevention, or to have a direct effect in restoring, correcting, or modifying physiological functions in humans. Some medications such as combination treatments include numerous active components that treat various symptoms or work in different ways. All drugs are manufactured by using two main constituents including API and excipient, wherein active pharmaceutical ingredient (API) is the essential ingredient, and the excipients are substances other than the drug that help in delivering the medication to body system.

The India active pharmaceutical ingredients market is estimated to be valued at US$ 19,993.2 million in 2021 and is expected to exhibit a CAGR of 8.3% during the forecast period (2021-2028).

Figure 1. India Active Pharmaceutical Ingredient Market in Terms of Value (US$ Million), By Region, 2021

India Active Pharmaceutical Ingredient  | Coherent Market Insights

Major pharmaceutical companies are focusing on expansion of their production in high potent APIs (HPAPIs), which is expected to boost the market growth during the forecast period

Rising number of key market players are focusing on the expansion of high potent active pharmaceutical ingredients (HPAPIs) production, considering investing in new HPAPIs production facilities, which is expected to drive the India active pharmaceutical ingredients market growth. For instance, in October 2017, Piramal Pharma Solutions (PPS), a contract development and manufacturing company, invested US$ 55 million to expand its API manufacturing capabilities and capacities across its Asia sites.

request-sample

India Active Pharmaceutical Ingredient Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 19,993.2 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 8.3% 2028 Value Projection: US$ 34,968.7 Mn
Geographies covered:
  • North India: Delhi, Uttar Pradesh, Rajasthan, Punjab, and Others
  • South India: Tamil Nadu, Kerala, Andhra Pradesh, Telangana, and Others
  • East India: Bihar, Jharkhand, West Bengal, and Others (North East India)
  • West India: Maharashtra, Goa, and Gujarat
  • Central India: Madhya Pradesh and Chhattisgarh
Segments covered:
  • By Product Type: Low Potent APIs, High Potent APIs
  • By Molecule Type: Acetaminophen, Naproxen, Dextromethorphan Hydrobromide, Gabapentin, Ciprofloxacin, Ofloxacin, Mirtazapine, Sotalol, Levetiracetam, Salmeterol, Salbutamol, Fexuprazan, Diclofenac, Azithromycin, Afatinib dimaleate, Apixaban, Bendamustine, Bosentan Monohydrate, Atorvastin Calcium, Atorvastin Calcium, Ibuprofen, Praziquantel, Oseltamivir - Process A, Lanthanum Carbonate Octa, Sevelamer Carbonate, Succinyl Choline Chloride, Others
  • By Formulation: Oral, Topical, Injectables, Drops
  • By Application: Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Dermatology, Respiratory, Ophthalmic, Others
Companies covered:

Teva Pharmaceutical Industries Ltd.,  Solara , Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.

Growth Drivers:
  • Increasing number of major pharmaceutical companies are focusing on expansion of their production in high potent APIs (HPAPIs)
  • Active pharmaceutical ingredients manufacturers are focusing on agreements
Restraints & Challenges:
  • Stringent regulatory activities included in the active pharmaceutical ingredient market

Figure 2. India Active Pharmaceutical lngredients Market Share in Terms of Value (US$ Mn), By Product Type, 2021

India Active Pharmaceutical Ingredient  | Coherent Market Insights

Active pharmaceutical ingredients manufacturers are engaging in business development strategies such as mergers and agreements, which is a major factor propelling the market growth over the forecast period

Active pharmaceutical ingredients manufacturers are focusing on entering into definitive agreements, which is expected to drive the India active pharmaceutical ingredients market growth over the forecast period. For instance, in October 2020, PAG, a major Asia-focused private equity company, and its grouping partners CX Partners and Samara Capital agreed to buy a controlling position in Anjan Drug Pvt. Ltd., a Chennai-based maker of active pharmaceutical ingredients (API).

India Active Pharmaceutical Ingredient Market– Impact of Coronavirus (COVID-19) Pandemic

COVID-19 has a three major impact on the economy, it directly affects production and demand, it disrupts distribution channels, and it has a financial impact on firms and financial markets. Due to national lockdowns, India is experiencing difficulties in transporting APIs or medicines from one location to another, which is having a negative impact on the India active pharmaceutical ingredients market.

Furthermore, the COVID-19 pandemic has resulted in increasing medication prices. For instance, Penicillin's raw material, Penicillium chrysogenum, raised its price by 40% in just one month. In January 2020, according to the Pharmaceutical Export Promotion Council (PHARMEXCIL), which is part of India's Ministry of Commerce and Industry, the price of API Penicillin increased from Rs.454.00 (US$ 6.16) to Rs.639.00 (US$ 8.69) per unit.

India Active Pharmaceutical Ingredient Market: Restraint

Stringent regulatory activities included in the active pharmaceutical ingredient market is expected to hinder the market growth during the forecast period. Stringent global regulatory policies on enhanced Current Good Manufacturing Practice (CGMP) guidelines, facility certification, quality valuations of active pharmaceutical ingredients manufacturing,  strict surprise inspection regimes, and increased supply chain security issues across emerging economies have a large impact on the cost of final active pharmaceutical ingredients products.

Key Players                                                               

Major players operating in the India active pharmaceutical ingredient market include Teva Pharmaceutical Industries Ltd., Solara, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.

The active pharmaceutical ingredient (API) in a medication is the component that causes the desired effects. Active pharmaceutical ingredients are mostly manufactured at big manufacturing factories and its manufacturing process involves a series of operations such as multi-step chemical synthesis, fermentation, purification, crystallization, drying, milling, packing, labeling, and testing. They may also be examined by foreign government agencies, and third-party corporations may conduct audits at API facilities. APIs must meet the quality and safety requirements imposed by the producing country. Even if the production is outsourced, API businesses must adhere to the rigorous requirements of the relevant health authorities. Most of the active pharmaceutical ingredient companies are headquartered in India. However, because the bulk API production takes place in mostly Asian countries such as China, they are the source of the majority of APIs produced worldwide.

Market Dynamics

The active pharmaceutical ingredients manufacturers are starting production units in India to remain competitive and gain benefit over other competitors, which is projected to fuel the market growth during the forecast period.  For instance, in February 2017, Nacto pharma, an Indian multinational pharmaceutical company, planned to invest around US$ 1 Billion and expand its active pharmaceutical ingredient (API) and intermediates manufacturing facility in Tamil Nadu.

Key features of the study:

  • This report provides an in-depth analysis of the India active pharmaceutical ingredient market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the India active pharmaceutical ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Salora, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The India active pharmaceutical ingredient market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredient market

Detailed Segmentation:

  • India Active Pharmaceutical Ingredient Market, By Product Type:
    • Low Potent APIs
    • High Potent APIs
  • India Active Pharmaceutical Ingredient Market, By Molecular Type:
    • Acetaminophen
    • Naproxen
    • Dextromethorphan Hydrobromide
    • Gabapentin
    • Ciprofloxacin
    • Ofloxacin
    • Mirtazapine
    • Sotalol
    • Levetiracetam
    • Salmeterol
    • Salbutamol
    • Fexuprazan
    • Diclofenac
    • Azithromycin
    • Afatinib dimaleate
    • Apixaban
    • Bendamustine
    • Bosentan Monohydrate
    • Atorvastin Calcium
    • Atorvastin Calcium
    • Ibuprofen
    • Praziquantel
    • Oseltamivir - Process A
    • Lanthanum Carbonate Octa
    • Sevelamer Carbonate
    • Succinyl Choline Chloride
    • Others
  • India Active Pharmaceutical Ingredient Market, By Formulation:
    • Oral
    • Topical
    • Injectables
    • Drops
  • India Active Pharmaceutical Ingredient Market, By Application:
    • Diabetes
    • Oncology
    • Cardiovascular
    • CNS
    • Analgesics
    • Dermatology
    • Respiratory
    • Ophthalmic
    • Others
  • India Active Pharmaceutical Ingredient Market, By Region:
    • North India
      • By Product Type
        • Low Potent APIs
        • High Potent APIs
      • By Molecular Type
        • Acetaminophen
        • Naproxen
        • Dextromethorphan Hydrobromide
        • Gabapentin
        • Ciprofloxacin
        • Ofloxacin
        • Mirtazapine
        • Sotalol
        • Levetiracetam
        • Salmeterol
        • Salbutamol
        • Fexuprazan
        • Diclofenac
        • Azithromycin
        • Afatinib dimaleate
        • Apixaban
        • Bendamustine
        • Bosentan Monohydrate
        • Atorvastin Calcium
        • Atorvastin Calcium
        • Ibuprofen
        • Praziquantel
        • Oseltamivir - Process A
        • Lanthanum Carbonate Octa
        • Sevelamer Carbonate
        • Succinyl Choline Chloride
        • Others
      • By Formulation
        • Oral
        • Topical
        • Injectables
        • Drops
      • By Application
        • Diabetes
        • Oncology
        • Cardiovascular
        • CNS
        • Analgesics
        • Dermatology
        • Respiratory
        • Ophthalmic
        • Others
      • By States
        • Delhi
        • Uttar Pradesh
        • Rajasthan
        • Punjab
        • Others
    • South India
      • By Product Type
        • Low Potent APIs
        • High Potent APIs
      • By Molecular Type
        • Acetaminophen
        • Naproxen
        • Dextromethorphan Hydrobromide
        • Gabapentin
        • Ciprofloxacin
        • Ofloxacin
        • Mirtazapine
        • Sotalol
        • Levetiracetam
        • Salmeterol
        • Salbutamol
        • Fexuprazan
        • Diclofenac
        • Azithromycin
        • Afatinib dimaleate
        • Apixaban
        • Bendamustine
        • Bosentan Monohydrate
        • Atorvastin Calcium
        • Atorvastin Calcium
        • Ibuprofen
        • Praziquantel
        • Oseltamivir - Process A
        • Lanthanum Carbonate Octa
        • Sevelamer Carbonate
        • Succinyl Choline Chloride
        • Others
      • By Formulation
        • Oral
        • Topical
        • Injectables
        • Drops
      • By Application
        • Diabetes
        • Oncology
        • Cardiovascular
        • CNS
        • Analgesics
        • Dermatology
        • Respiratory
        • Ophthalmic
        • Others
      • By States
        • Tamil Nadu
        • Kerala
        • Andhra Pradesh
        • Telangana
        • Others
    • East India
      • By Product Type
        • Low Potent APIs
        • High Potent APIs
      • By Molecular Type
        • Acetaminophen
        • Naproxen
        • Dextromethorphan Hydrobromide
        • Gabapentin
        • Ciprofloxacin
        • Ofloxacin
        • Mirtazapine
        • Sotalol
        • Levetiracetam
        • Salmeterol
        • Salbutamol
        • Fexuprazan
        • Diclofenac
        • Azithromycin
        • Afatinib dimaleate
        • Apixaban
        • Bendamustine
        • Bosentan Monohydrate
        • Atorvastin Calcium
        • Atorvastin Calcium
        • Ibuprofen
        • Praziquantel
        • Oseltamivir - Process A
        • Lanthanum Carbonate Octa
        • Sevelamer Carbonate
        • Succinyl Choline Chloride
        • Others
      • By Formulation
        • Oral
        • Topical
        • Injectables
        • Drops
      • By Application
        • Diabetes
        • Oncology
        • Cardiovascular
        • CNS
        • Analgesics
        • Dermatology
        • Respiratory
        • Ophthalmic
        • Others
      • By States
        • Bihar
        • Jharkhand
        • West Bengal
        • Others (North East India)
    • West India
      • By Product Type
        • Low Potent APIs
        • High Potent APIs
      • By Molecular Type
        • Acetaminophen
        • Naproxen
        • Dextromethorphan Hydrobromide
        • Gabapentin
        • Ciprofloxacin
        • Ofloxacin
        • Mirtazapine
        • Sotalol
        • Levetiracetam
        • Salmeterol
        • Salbutamol
        • Fexuprazan
        • Diclofenac
        • Azithromycin
        • Afatinib dimaleate
        • Apixaban
        • Bendamustine
        • Bosentan Monohydrate
        • Atorvastin Calcium
        • Atorvastin Calcium
        • Ibuprofen
        • Praziquantel
        • Oseltamivir - Process A
        • Lanthanum Carbonate Octa
        • Sevelamer Carbonate
        • Succinyl Choline Chloride
        • Others
      • By Formulation
        • Oral
        • Topical
        • Injectables
        • Drops
      • By Application
        • Diabetes
        • Oncology
        • Cardiovascular
        • CNS
        • Analgesics
        • Dermatology
        • Respiratory
        • Ophthalmic
        • Others
      • By States
        • Maharashtra
        • Goa
        • Gujarat
    • Central India
      • By Product Type
        • Low Potent APIs
        • High Potent APIs
      • By Molecular Type
        • Acetaminophen
        • Naproxen
        • Dextromethorphan Hydrobromide
        • Gabapentin
        • Ciprofloxacin
        • Ofloxacin
        • Mirtazapine
        • Sotalol
        • Levetiracetam
        • Salmeterol
        • Salbutamol
        • Fexuprazan
        • Diclofenac
        • Azithromycin
        • Afatinib dimaleate
        • Apixaban
        • Bendamustine
        • Bosentan Monohydrate
        • Atorvastin Calcium
        • Atorvastin Calcium
        • Ibuprofen
        • Praziquantel
        • Oseltamivir - Process A
        • Lanthanum Carbonate Octa
        • Sevelamer Carbonate
        • Succinyl Choline Chloride
        • Others
      • By Formulation
        • Oral
        • Topical
        • Injectables
        • Drops
      • By Application
        • Diabetes
        • Oncology
        • Cardiovascular
        • CNS
        • Analgesics
        • Dermatology
        • Respiratory
        • Ophthalmic
        • Others
      • By States
        • Madhya Pradesh
        • Chhattisgarh
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Salora
    • Aurobindo Pharma Limited
    • Reddy's Laboratories
    • Lupin Limited
    • Sun Pharmaceutical Industries Limited
    • Divi’s Laboratories Ltd.
    • Aarti Drugs Ltd.
    • Hikal Ltd.
    • Neuland Labs
    • Century Pharmaceuticals Ltd.
    • Proventus Life Sciences Pvt Ltd
    • Chiral Drugs Pvt Ltd
    • USV Private Limited
    • ASolution Pharmaceuticals Pvt. Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Molecule Type
      • Market Snapshot, By Formulation
      • Market Snapshot, By Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
    • Impact Analysis
    • Pipeline Analysis
    • Regulatory Scenario
    • Market Trends
    • Key Developments
    • Epidemiology
    • PEST Analysis
    • Brand Analysis
  4. India Active Pharmaceutical Ingredients Market– Impact of Coronavirus (COVID-19) Pandemic
    • COVID-19 Epidemiology
    • Supply and Demand Analysis
    • Key Developments
  5. India Active Pharmaceutical Ingredients Market, By Product Type, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • High Potent APIs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Low Potent APIs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  6. India Active Pharmaceutical Ingredients Market, By Molecule Type, By , 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Acetaminophen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Naproxen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Dextromethorphan Hydrobromide
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ciprofloxacin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ofloxacin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Mirtazapine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Sotalol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Levetiracetam
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Salmeterol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Salbutamol
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Fexuprazan
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Diclofenac
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Pantoprazole
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Azithromycin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Afatinib dimaleate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Apixaban
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Bendamustine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Bosentan Monohydrate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Atorvastin Calcium
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ibuprofen
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Gabapentin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Praziquantel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Oseltamivir - Process A
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Lanthanum Carbonate OCTA
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Sevelamer Carbonate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Succinyl Choline Chloride
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  7. India Active Pharmaceutical Ingredients Market, By Formulation, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Injectables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Drops
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  8. India Active Pharmaceutical Ingredients Market, By Application, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • CNS
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Ophthalmic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  9. India Active Pharmaceutical Ingredients Market, By Region, 2017 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2017 – 2028
      • Segment Trends
    • North India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • South India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • East India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • West India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
    • Central India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Solara
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aurobindo Pharma Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Reddy's Laboratories
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Lupin Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Divi’s Laboratories Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Aarti Drugs Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Hikal Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Neuland Labs
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Century Pharmaceuticals Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Proventus Life Sciences Pvt Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Chiral Drugs Pvt Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • USV Private Limited
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • ASolution Pharmaceuticals Pvt. Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
    • Analyst Views
  11. Section
    • Research Methodology
    • About us

*Browse 28 market data tables and 34 figures on "India Active Pharmaceutical Ingredient Market” - forecast to 2028

FAQgrowicon

Frequently Asked Questions

The India active pharmaceutical ingredient market is estimated to be valued at US$ 19,993.2 million in 2021 and is expected to exhibit a CAGR of 8.3% between 2021 and 2028.
Factors such as increasing number of major pharmaceutical companies are focusing on expansion of their production in high potent APIs (HPAPIs) is expected to drive the market growth during the forecast period.
Low potent APIs segment is expected to hold a major market share during the forecast period in the product type segment.
The major factor hampering growth of the India active pharmaceutical ingredient market include stringent regulatory activities included in the market.
Major players operating in the market include Teva Pharmaceutical Industries Ltd., Solara, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.